Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.17
$0.087.34%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | 76.83M | 76.83M |
| Total Depreciation and Amortization | -- | -- | -- | 14.43M | 14.43M |
| Total Amortization of Deferred Charges | -- | -- | -- | 885.70K | 885.70K |
| Total Other Non-Cash Items | -- | -- | -- | 50.26M | 50.26M |
| Change in Net Operating Assets | -- | -- | -- | -40.38M | -40.38M |
| Cash from Operations | -- | -- | -- | 102.03M | 102.03M |
| Capital Expenditure | -- | -- | -- | -10.29M | -10.29M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 636.00K | 636.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -12.15M | -12.15M |
| Cash from Investing | -- | -- | -- | -21.80M | -21.80M |
| Total Debt Issued | -- | -- | -- | 4.05B | 4.05B |
| Total Debt Repaid | -- | -- | -- | -4.01B | -4.01B |
| Issuance of Common Stock | -- | -- | -- | 1.83B | 1.86B |
| Repurchase of Common Stock | -- | -- | -- | -1.89B | -1.89B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -45.73M | -45.73M |
| Other Financing Activities | -- | -- | -- | -787.81M | -820.09M |
| Cash from Financing | -- | -- | -- | -92.62M | -92.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | 4.79M | 4.79M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -7.60M | -7.60M |